Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline for M. perstans and Mycobacterial Immunity
NCT02281643Phase 2Completed
- Sponsor
- Kwame Nkrumah University of Science and Technology
- Start
- Oct 2014
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of doxycycline in Mansonella perstans infection (2 arms), sponsored by Kwame Nkrumah University of Science and Technology. Primary endpoint: Microfilarial assessment at 12 months. Started Oct 2014; status: completed.
02
Drugs
doxycycline
03
Conditions
Mansonella perstans infection
Beyond the preview
Go deeper on NCT02281643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02281643.